Exvastat Enters COVID-19 Arena With Intravenous Imatinib
Reformulating Cancer Blockbuster For ARDS
Executive Summary
The UK firm has tapped into EU funds through an Irish subsidiary to advance its treatment for acute respiratory distress syndrome based on a reformulation of Novartis's Gleevec.